Cargando…

MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells

Methyl-CpG binding protein 2 (MeCP2) is a ubiquitous transcriptional regulator. The study of this protein has been mainly focused on the central nervous system because alterations of its expression are associated with neurological disorders such as Rett syndrome. However, young patients with Rett sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliani, Angelica, Sabbatinelli, Jacopo, Amatori, Stefano, Graciotti, Laura, Silvestrini, Andrea, Matacchione, Giulia, Ramini, Deborah, Mensà, Emanuela, Prattichizzo, Francesco, Babini, Lucia, Mattiucci, Domenico, Busilacchi, Elena Marinelli, Bacalini, Maria Giulia, Espinosa, Emma, Lattanzio, Fabrizia, Procopio, Antonio Domenico, Olivieri, Fabiola, Poloni, Antonella, Fanelli, Mirco, Rippo, Maria Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971129/
https://www.ncbi.nlm.nih.gov/pubmed/36847916
http://dx.doi.org/10.1007/s00018-023-04719-6
_version_ 1784898044096937984
author Giuliani, Angelica
Sabbatinelli, Jacopo
Amatori, Stefano
Graciotti, Laura
Silvestrini, Andrea
Matacchione, Giulia
Ramini, Deborah
Mensà, Emanuela
Prattichizzo, Francesco
Babini, Lucia
Mattiucci, Domenico
Busilacchi, Elena Marinelli
Bacalini, Maria Giulia
Espinosa, Emma
Lattanzio, Fabrizia
Procopio, Antonio Domenico
Olivieri, Fabiola
Poloni, Antonella
Fanelli, Mirco
Rippo, Maria Rita
author_facet Giuliani, Angelica
Sabbatinelli, Jacopo
Amatori, Stefano
Graciotti, Laura
Silvestrini, Andrea
Matacchione, Giulia
Ramini, Deborah
Mensà, Emanuela
Prattichizzo, Francesco
Babini, Lucia
Mattiucci, Domenico
Busilacchi, Elena Marinelli
Bacalini, Maria Giulia
Espinosa, Emma
Lattanzio, Fabrizia
Procopio, Antonio Domenico
Olivieri, Fabiola
Poloni, Antonella
Fanelli, Mirco
Rippo, Maria Rita
author_sort Giuliani, Angelica
collection PubMed
description Methyl-CpG binding protein 2 (MeCP2) is a ubiquitous transcriptional regulator. The study of this protein has been mainly focused on the central nervous system because alterations of its expression are associated with neurological disorders such as Rett syndrome. However, young patients with Rett syndrome also suffer from osteoporosis, suggesting a role of MeCP2 in the differentiation of human bone marrow mesenchymal stromal cells (hBMSCs), the precursors of osteoblasts and adipocytes. Here, we report an in vitro downregulation of MeCP2 in hBMSCs undergoing adipogenic differentiation (AD) and in adipocytes of human and rat bone marrow tissue samples. This modulation does not depend on MeCP2 DNA methylation nor on mRNA levels but on differentially expressed miRNAs during AD. MiRNA profiling revealed that miR-422a and miR-483-5p are upregulated in hBMSC-derived adipocytes compared to their precursors. MiR-483-5p, but not miR-422a, is also up-regulated in hBMSC-derived osteoblasts, suggesting a specific role of the latter in the adipogenic process. Experimental modulation of intracellular levels of miR-422a and miR-483-5p affected MeCP2 expression through direct interaction with its 3′ UTR elements, and the adipogenic process. Accordingly, the knockdown of MeCP2 in hBMSCs through MeCP2-targeting shRNA lentiviral vectors increased the levels of adipogenesis-related genes. Finally, since adipocytes released a higher amount of miR-422a in culture medium compared to hBMSCs we analyzed the levels of circulating miR-422a in patients with osteoporosis—a condition characterized by increased marrow adiposity—demonstrating that its levels are negatively correlated with T- and Z-scores. Overall, our findings suggest that miR-422a has a role in hBMSC adipogenesis by downregulating MeCP2 and its circulating levels are associated with bone mass loss in primary osteoporosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-023-04719-6.
format Online
Article
Text
id pubmed-9971129
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99711292023-03-01 MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells Giuliani, Angelica Sabbatinelli, Jacopo Amatori, Stefano Graciotti, Laura Silvestrini, Andrea Matacchione, Giulia Ramini, Deborah Mensà, Emanuela Prattichizzo, Francesco Babini, Lucia Mattiucci, Domenico Busilacchi, Elena Marinelli Bacalini, Maria Giulia Espinosa, Emma Lattanzio, Fabrizia Procopio, Antonio Domenico Olivieri, Fabiola Poloni, Antonella Fanelli, Mirco Rippo, Maria Rita Cell Mol Life Sci Original Article Methyl-CpG binding protein 2 (MeCP2) is a ubiquitous transcriptional regulator. The study of this protein has been mainly focused on the central nervous system because alterations of its expression are associated with neurological disorders such as Rett syndrome. However, young patients with Rett syndrome also suffer from osteoporosis, suggesting a role of MeCP2 in the differentiation of human bone marrow mesenchymal stromal cells (hBMSCs), the precursors of osteoblasts and adipocytes. Here, we report an in vitro downregulation of MeCP2 in hBMSCs undergoing adipogenic differentiation (AD) and in adipocytes of human and rat bone marrow tissue samples. This modulation does not depend on MeCP2 DNA methylation nor on mRNA levels but on differentially expressed miRNAs during AD. MiRNA profiling revealed that miR-422a and miR-483-5p are upregulated in hBMSC-derived adipocytes compared to their precursors. MiR-483-5p, but not miR-422a, is also up-regulated in hBMSC-derived osteoblasts, suggesting a specific role of the latter in the adipogenic process. Experimental modulation of intracellular levels of miR-422a and miR-483-5p affected MeCP2 expression through direct interaction with its 3′ UTR elements, and the adipogenic process. Accordingly, the knockdown of MeCP2 in hBMSCs through MeCP2-targeting shRNA lentiviral vectors increased the levels of adipogenesis-related genes. Finally, since adipocytes released a higher amount of miR-422a in culture medium compared to hBMSCs we analyzed the levels of circulating miR-422a in patients with osteoporosis—a condition characterized by increased marrow adiposity—demonstrating that its levels are negatively correlated with T- and Z-scores. Overall, our findings suggest that miR-422a has a role in hBMSC adipogenesis by downregulating MeCP2 and its circulating levels are associated with bone mass loss in primary osteoporosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-023-04719-6. Springer International Publishing 2023-02-27 2023 /pmc/articles/PMC9971129/ /pubmed/36847916 http://dx.doi.org/10.1007/s00018-023-04719-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Giuliani, Angelica
Sabbatinelli, Jacopo
Amatori, Stefano
Graciotti, Laura
Silvestrini, Andrea
Matacchione, Giulia
Ramini, Deborah
Mensà, Emanuela
Prattichizzo, Francesco
Babini, Lucia
Mattiucci, Domenico
Busilacchi, Elena Marinelli
Bacalini, Maria Giulia
Espinosa, Emma
Lattanzio, Fabrizia
Procopio, Antonio Domenico
Olivieri, Fabiola
Poloni, Antonella
Fanelli, Mirco
Rippo, Maria Rita
MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
title MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
title_full MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
title_fullStr MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
title_full_unstemmed MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
title_short MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
title_sort mir-422a promotes adipogenesis via mecp2 downregulation in human bone marrow mesenchymal stem cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971129/
https://www.ncbi.nlm.nih.gov/pubmed/36847916
http://dx.doi.org/10.1007/s00018-023-04719-6
work_keys_str_mv AT giulianiangelica mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT sabbatinellijacopo mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT amatoristefano mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT graciottilaura mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT silvestriniandrea mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT matacchionegiulia mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT raminideborah mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT mensaemanuela mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT prattichizzofrancesco mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT babinilucia mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT mattiuccidomenico mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT busilacchielenamarinelli mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT bacalinimariagiulia mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT espinosaemma mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT lattanziofabrizia mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT procopioantoniodomenico mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT olivierifabiola mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT poloniantonella mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT fanellimirco mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells
AT rippomariarita mir422apromotesadipogenesisviamecp2downregulationinhumanbonemarrowmesenchymalstemcells